HLP003 has been granted Breakthrough Therapy Designation by the FDA, which makes HLP003 eligible for an expedited review pathway, with the potential to reduce drug development timelines. Helus Pharma ...
A new YouTube Culture & Trends report shows how creators and hobbyists use generative AI video to express personal identity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results